Clinical trial

Effect of Tadalafil on Insulin Secretion and Insulin Sensitivity in Obese Men.

NCT02595684

Study summary

ClinicalTrials.gov

Effect of Tadalafil on Insulin Secretion and Insulin Sensitivity in Obese Men.

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Mapped RxNorm record Tadalafil Normalized identity: tadalafil View linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2015-08-01

PhasePHASE4

Conditions

Obesityverified · MONDO: obesity disorder

Interventions

TadalafilDRUG · verified · RxNorm: tadalafil

PlaceboDRUG

Sponsors & collaborators

University of Guadalajaralead sponsor

Mapped research locations

GuadalajaraJalisco, Mexico1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02595684 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.